SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Peter F.A. Mulders, Arturo Molina, Michael Marberger, Fred Saad, Celestia S. Higano, Kim N. Chi, Jinhui Li, Thian Kheoh, Christopher M. Haqq, Karim Fizazi, Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy, European Urology, 2014, 65, 5, 875

    CrossRef

  2. 2
    Chris R. Cardwell, Evelyn M. Flahavan, Carmel M. Hughes, Helen G. Coleman, Joe M. O’Sullivan, Des G. Powe, Liam J. Murray, Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink, Cancer Causes & Control, 2014, 25, 1, 33

    CrossRef

  3. 3
    F.-R. Ferrand, M. Pavic, Traitements ciblant la voie du récepteur aux androgènes dans le cancer de la prostate, La Revue de Médecine Interne, 2014, 35, 10, 670

    CrossRef

  4. 4
    A Omlin, C J Pezaro, S Zaidi, D Lorente, D Mukherji, D Bianchini, R Ferraldeschi, S Sandhu, D Dearnaley, C Parker, N Van As, J S de Bono, G Attard, Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer, British Journal of Cancer, 2013, 109, 5, 1079

    CrossRef

  5. 5
    Imhokhai Ogah, Richard J. Wassersug, How reliable are “reputable sources” for medical information on the Internet? The case of hormonal therapy to treat prostate cancer, Urologic Oncology: Seminars and Original Investigations, 2013, 31, 8, 1546

    CrossRef

  6. 6
    Aurelius Omlin, Carmel Pezaro, Johann de Bono, Targeted Therapies in Oncology, Second Edition, 2013,

    CrossRef